Literature DB >> 19041441

Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.

Birgitta Segebladh1, Anna Borgström, Viveca Odlind, Marie Bixo, Inger Sundström-Poromaa.   

Abstract

BACKGROUND: Negative mood symptoms remain one of the major reasons for discontinuation of combined oral contraceptive pills (COCs). The primary aim of this study was to compare the prevalence of mood and anxiety disorders in women with different experience of COCs. STUDY
DESIGN: Thirty women currently on COCs with no report of adverse mood symptoms, 28 women currently on COCs and experiencing mood-related side effects, 33 women who had discontinued COC use due to adverse mood effects and 27 women who had discontinued COC use for reasons other than adverse mood symptoms were included. Ongoing psychiatric disorders were evaluated by a structured psychiatric interview and prevalence rates of premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) were assessed by daily prospective ratings on the Cyclicity Diagnoser scale.
RESULTS: Women with ongoing or past experience of COC-induced adverse mood, more often suffered from mood disorders than women with no reports of adverse mood while on COC. The prevalence of prospectively defined PMS or PMDD did not differ between prior users with positive or negative experience. Women who had discontinued COC use due to adverse mood symptoms more often had had a legal abortion in the past.
CONCLUSION: Women with ongoing or past self-reported adverse mood effects from COCs had a significantly increased prevalence of mood disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041441     DOI: 10.1016/j.contraception.2008.08.001

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

1.  Young women's consistency of contraceptive use--does depression or stress matter?

Authors:  Kelli Stidham Hall; Caroline Moreau; James Trussell; Jennifer Barber
Journal:  Contraception       Date:  2013-06-12       Impact factor: 3.375

2.  Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women.

Authors:  Kelli Stidham Hall; Katharine O'Connell White; Vaughn I Rickert; Nancy Reame; Carolyn Westhoff
Journal:  Contraception       Date:  2012-06-04       Impact factor: 3.375

3.  Discontinuation of hormonal contraception due to changes in mood and decreases in sexual desire: the role of adverse childhood experiences.

Authors:  Andrew M Novick; Rachel L Johnson; Aaron Lazorwitz; Anna Belyavskaya; Lily Berkowitz; Aileen Norton; Mary D Sammel; C Neill Epperson
Journal:  Eur J Contracept Reprod Health Care       Date:  2022-02-08       Impact factor: 1.752

4.  Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods.

Authors:  Kelli Stidham Hall; Caroline Moreau; James Trussell; Jennifer Barber
Journal:  J Adolesc Health       Date:  2013-04-09       Impact factor: 5.012

5.  Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats.

Authors:  Francesca Santoru; Roberta Berretti; Andrea Locci; Patrizia Porcu; Alessandra Concas
Journal:  Psychopharmacology (Berl)       Date:  2014-04-13       Impact factor: 4.530

6.  Anxiety Disorders Among Women: A Female Lifespan Approach.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-04-10

7.  A comparison of second and third generations combined oral contraceptive pills' effect on mood.

Authors:  Mahnaz Shahnazi; Azizeh Farshbaf Khalili; Fatemeh Ranjbar Kochaksaraei; Mohammad Asghari Jafarabadi; Kamal Gaza Banoi; Jila Nahaee; Somayeh Bayati Payan
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

8.  Prenatal levonorgestrel exposure induces autism-like behavior in offspring through ERβ suppression in the amygdala.

Authors:  Yuanlin Zou; Qiaomei Lu; Dan Zheng; Zhigang Chu; Zhaoyu Liu; Haijia Chen; Qiongfang Ruan; Xiaohu Ge; Ziyun Zhang; Xiaoyan Wang; Wenting Lou; Yongjian Huang; Yifei Wang; Xiaodong Huang; Zhengxiang Liu; Weiguo Xie; Yikai Zhou; Paul Yao
Journal:  Mol Autism       Date:  2017-08-17       Impact factor: 7.509

9.  Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women.

Authors:  Sofia Zettermark; Raquel Perez Vicente; Juan Merlo
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

10.  Prevalence of contraceptive use and its association with depression among women in the Jazan province of Saudi Arabia.

Authors:  Mashael Alfaifi; Ali H Najmi; Khadija H Swadi; Abdullah A Almushtawi; Sattam A Jaddoh
Journal:  J Family Med Prim Care       Date:  2021-07-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.